StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report released on Sunday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of Global Cord Blood stock opened at $1.75 on Friday. The firm has a market cap of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. The stock’s 50-day moving average is $1.33 and its 200 day moving average is $1.38. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.
Global Cord Blood Company Profile
Read More
- Five stocks we like better than Global Cord Blood
- 3 Warren Buffett Stocks to Buy Now
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- Stock Analyst Ratings and Canadian Analyst Ratings
- Lowe’s Stock: Hold Now, Buy it When it Dips
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.